With the FDA emergency use authorization of the Pfizer-BioNTech COVID-19 vaccine on December 11, 2020 and the Moderna vaccine on December 18, 2020, the Allergy Group recommends the following guidance for physicians and other providers related to risk of an allergic reaction on vaccination.